Back to company

Scanbio Denmark ApS: Financial statements 2025

CVR: 42107654

Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. That is a decrease of 67.7% compared with the year before. Equity amounted to DKK 10,249,140. The solvency ratio was 75.8%. The company had 6 employees in the financial year.

Gross Profit
5,295,465 kr.
Profit/Loss
-135,927 kr.
Equity
10,249,140 kr.
Total Assets
13,530,205 kr.
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-5.3 mio.-136 t.10.2 mio.6
2024-16.4 mio.2 mio.10.4 mio.4
2023-11.2 mio.4 mio.8.4 mio.4
2022-8.1 mio.3.9 mio.4.4 mio.4
2021-2.5 mio.448 t.488 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Scanbio Denmark ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Scanbio Denmark ApS: The 2024 annual report is outJun 30, 2025

Scanbio Denmark ApS has published its annual report for 2024. Gross profit came to DKK 16,399,410, and the net result was DKK 1,999,265.

Scanbio Denmark ApS appoints new auditorJun 23, 2025

As of June 23, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Scanbio Denmark ApS.

Tor Vikenes joins Scanbio Denmark ApS as directorJun 23, 2025

As of June 23, 2025, Tor Vikenes is registered as director of Scanbio Denmark ApS.

Kamel Gabriel El Khaloui steps down as director of Scanbio Denmark ApSJun 23, 2025

As of June 23, 2025, Kamel Gabriel El Khaloui has stepped down as director of Scanbio Denmark ApS.

About Scanbio Denmark ApS

Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity amounted to DKK 10,249,140.

Other financial years